Education
About Us
Working with TipRanks
Follow Us
JAN STAHLBERG Insider Profile
4 Followers
JAN STAHLBERG, Ten Percent Owner at Diamedica Therapeutics, holds 6.76M shares in Diamedica Therapeutics (Ticker: DMAC). Most recently, JAN STAHLBERG Bought $1,542,857 shares of Diamedica Therapeutics on Jul 25, 2025 for an estimated value of 5.40M.
JAN STAHLBERG Diamedica Therapeutics (DMAC)Ten Percent Owner
Diamedica Therapeutics (DMAC)
Ten Percent Owner
Ranked #50,472 out of 102,830 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+1.30%
Average return per transaction
Time Frame
Compare to
Insider Roles
Ten Percent Owner
Roles that JAN STAHLBERG holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 01, 2024 - Jul 01, 2025
Return:+21.00%
The most profitable trade made by JAN STAHLBERG
JAN STAHLBERG's Trading History
List of latest transactions for each holding click on a transaction to see JAN STAHLBERG's performance on stock
You May Also Like
JAN STAHLBERG insider profile FAQ
What is the percentage of profitable transactions made by JAN STAHLBERG?
The percentage of profitable transactions made by JAN STAHLBERG is 50%.
What is the average return per transaction made by JAN STAHLBERG?
The average return per transaction made by JAN STAHLBERG is 1.30%.
What stocks does JAN STAHLBERG hold?
JAN STAHLBERG holds: DMAC stocks.
What was JAN STAHLBERG’s latest transaction?
JAN STAHLBERG latest transaction was an Informative Buy of $5.40M.
What was JAN STAHLBERG's most profitable transaction?
JAN STAHLBERG’s most profitable transaction was an Informative Buy of DMAC stock on July 1, 2024. The return on the trade was 21.00%.
What is JAN STAHLBERG's role in Diamedica Therapeutics?
JAN STAHLBERG's role in Diamedica Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.